FOXM1 and neoplasm: By integrating transcriptomic profiling, functional assays, and immune-activated three-dimensional spheroid models, we provide compelling evidence that HO-1197 exerts its therapeutic effects through the induction of ROS-mediated DNA damage, FoxM1-targeted transcriptional disruption, and remodeling of the tumor immune microenvironment.